MSB 2.17% $1.13 mesoblast limited

We are the real deal, page-2

  1. 1,250 Posts.
    lightbulb Created with Sketch. 1400
    OK, this is a neat summary of the possibilities of stem cells for disc disease but it doesn't add any confidence for investors.

    The article is basically a self-administered pat on the back for St George, Utah, putting itself on the map. Nothing wrong with that.  The Spine Center there must be a centre of excellence and its contribution is appreciated.

    The MSB spokesperson goes very close to the wind, in my opinion, almost forecasting success. You wouldn't hear SI being so strong.   Note that the people at the Spine Center actually doing the work and seeing the results are a lot more circumspect.  The MSB statements are hopeful enthusiastic opinions and not appropriate without at least a safe harbour cover. It is not the "gold standard" until FDA says so. Mere submission isn't enough.

    Anyway Yankee, please keep your energetic trawling going. You have found some encouraging stuff other times.
    Last edited by benelong: 02/04/16
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.